Netherlands-based Protix has received €45 million (US$50.38 million) in funding from by Aqua-Spark, Rabobank, BOM and other private investors. ###Protix breeds insects for animal feed, as insects offer a low-impact protein alternative that can be cultivated on a variety of food scalcium citrate for salecraps.###The company has turned insect production into a commercial success by serving the animal feed industry, while also developing food applications for consumers. ###Their products are used in over 12 countries to date – in feed applications ranging from pig and poultry to pet food specialties. ###One of the investors Aqua-Spark was interested in Protix promising uses for aquaculture. ###Fish raised using sustainable aquaculture methods offer a solution to the global food crisis because they have the least environmental impact of any animal protein. ###Protix has thus seen to have the potential to further elevate aquaculture, while solving feed challenges across multiple industries.###Meanwhile, Rabobank has been involved withferrous gluconate 324 Protix from its start, and continues to support the insect company today as the core bank in its latest round of funding. ###The bankcitracal d maximum was introduced to Protix through the Dutch Green Tech Fund (currently Shift Invest).###It recently collaborated with Bühler to accelerate the standardization and roll-out of insect rearing and pkirkland signature calcium citrate magnesium and zinc detailsrocessing equipmentcitracal 1500 mg globally.###Protix was founded in 2009 by two former McKinsey & Company colleagues, Kees Aarts and Tarique Arsiwalla.